Plain English Summary
Background and study aims.
We know that many patients who are at high risk of heart disease or stroke do not receive treatment. Treatments include drugs to lower blood pressure and drugs to reduce cholesterol levels (statins). A new process was put in place in general practices in Sandwell (West Midlands) to help identify untreated patients at high risk of heart disease. The aim of this study was to find out whether this process resulted in more high risk patients being started on treatment. If successful the study may lead to similar systems being adopted in other parts of the UK, which should result in more successful prevention of heart disease and stroke.
Who can participate?
The participants in this trial were general practices in Sandwell (West Midlands). Individuals identified as being at high risk of heart disease in these participating general practices were invited for check ups.
What does the study involve?
In the participating general practices the general practice computer system was used to identify patients who are at high risk of heart disease or stroke but are currently not receiving any treatment. The study included only patients aged 35 to 74 who do not already have heart disease or diabetes: patients with heart disease or diabetes should already be receiving treatment. The patients identified by the computer system as high risk were sent letters inviting them for a check up in their own general practice by a Project Nurse. The letter indicated that they might be offered treatment. The plan was to introduce this system across all general practices in Sandwell. However, it was not possible to implement this in all practices at the same time. Practices were randomly allocated to have the computer search and Project Nurse earlier or later in the course of the project. In order to determine whether this is an effective way of identifying high risk patients for treatment, the study looked at how many high risk patients were started on treatment before the computer search was undertaken and how many were started on treatment after the computer search was carried out, the invitations were sent and the Project Nurse was undertaking check ups in the practice.
What are the possible benefits and risks of participating?
General practices that participated received help in identifying their high risk patients. Those patients identified were offered lifestyle advice and drugs to prevent heart disease in accordance with good medical practice. There were no risks associated with participating in the research programme.
Where is the study run from?
The study was run from the School of Health and Population Sciences of the University of Birmingham.
When is the study starting and how long is it expected to run for?
The study began in 2009 and is now completed.
Who is funding the study?
It was funded by the National Institute of Health Research (UK).
Who is the main contact?
Dr Tom Marshall
T.P.Marshall@bham.ac.uk
Trial website
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N/A
Study information
Scientific title
Evaluation of a programme of cardiovascular disease prevention in primary care: a cluster randomised controlled trial
Acronym
Study hypothesis
A programme of case finding targeted at high risk patients will result in more patients being started on preventive treatment than usual care.
On 10/07/2013 the target number of participants was changed from 1,254 to 6,250
Ethics approval
University of Birmingham ethics review committee, 07/06/2010, ERN_10-0429
Study design
Cluster randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
GP practices
Trial type
Prevention
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Cardiovascular disease
Intervention
This is a step-wedge cluster randomised controlled trial. Targeted case finding is being implemented in general practices. Practices are randomised to early (intervention) or later implementation (control).
Interventions:
Systematic invitation and cardiovascular risk factor assessment of individuals aged 35 to 74 who are untreated but at high risk of cardiovascular disease. These individuals will then be referred for appropriate lifestyle advice or preventive treatment in accordance with good clinical practice and treatment guidelines.
Intervention type
Other
Phase
Not Applicable
Drug names
Primary outcome measures
Number of eligible patients started on preventive treatment (aspirin, antihypertensives and statins).
All primary and secondary outcomes will be assessed at 3 months, 6 months and 1 year after the start of the study.
Secondary outcome measures
1. Changes in blood pressure, total cholesterol, HDL cholesterol and smoking status
Process outcomes:
2. Numbers of persons attending for CVD risk factor assessment
3. Numbers of those assessed who are confirmed as being eligible for treatment
All primary and secondary outcomes will be assessed at 3 months, 6 months and 1 year after the start of the study.
Overall trial start date
01/02/2008
Overall trial end date
01/05/2010
Reason abandoned
Eligibility
Participant inclusion criteria
Participating practices are identified by the participating primary care trusts.
Patients for inclusion in the prevention programme are identifed as follows. They must be registered at a participating practice. They must be aged between 35 and 74 and must not currently have coronary heart disease (CHD), not be on the diabetic register and not be currently receiving antihypertensive or statin treatment. From these patients are identified all those patients in whom a combination of risk factors indicates they are likely to be at greater than 20% ten-year risk of cardiovascular disease. These patients are considered eligible for inclusion in the cardiovascular prevention programme. These patients will be identified from primary care electronic medical records.
In summary:
1. Patients (both males and females) aged between 35 and 74
2. Patients who do not have CHD
3. Patients who are not diabetic
4. Patients who are not receiving antihypertensives or statins
5. Patients who are likely to be at greater than 20% ten-year CVD risk
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
At least 6,250 participants in at least 6 practices
Participant exclusion criteria
Patients who in the opinion of the practice staff are unable to benefit from cardiovascular risk factor assessment. For example, patients who are terminally ill.
In practice this means that once a list has been created of individuals who are untreated high risk patients are eligible to be invited for cardiovascular risk factor assessment, practice staff will review the list and identify patients who are known to be terminally ill or otherwise unsuitable for inclusion.
Recruitment start date
01/03/2008
Recruitment end date
01/05/2010
Locations
Countries of recruitment
United Kingdom
Trial participating centre
Unit of Public Health Epidemiology and Biostatistics
Birmingham
B15 2TT
United Kingdom
Trial participating centre
Sandwell Primary Care Trust
United Kingdom
Sponsor information
Organisation
University Hospitals Birmingham NHS Foundation Trust (UK)
Sponsor details
PO Box 9551
Main Drive
Queen Elizabeth Medical Centre
Birmingham
B15 2PR
United Kingdom
Sponsor type
Government
Website
Funders
Funder type
Government
Funder name
National Institute for Health Research (NIHR) (UK) - Collaborations for Leadership in Applied Health Research and Care (CLAHRC): The Birmingham and Black Country collaboration
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
To be confirmed at a later date
Intention to publish date
Participant level data
Available on request
Results - basic reporting
Publication summary
2012 protocol in http://www.ncbi.nlm.nih.gov/pubmed/23101763
Publication citations
-
Protocol
Marshall T, Caley M, Hemming K, Gill P, Gale N, Jolly K, Mixed methods evaluation of targeted case finding for cardiovascular disease prevention using a stepped wedged cluster RCT., BMC Public Health, 2012, 12, 908, doi: 10.1186/1471-2458-12-908.